SusanKSchultzMD

PubMed

• 1 citations
  Clozapine utilization at the United States Veterans Health Administration: a descriptive report of prescribing patterns and patient characteristics among Operation End...
  Zachary D. Zuschlag, Christopher A Fowler, Andrew R. Devendorf, Vanessa Panaite, Olga Efimova
  International Clinical Psychopharmacology. 2020-11-01
• 2 citations
  Antidepressant Augmentation: A Review of the Literature and a Review of the Pharmacoeconomic Considerations.
  Glenn Catalano, Rhonda A Robeel, Grace A Cheney, Benjamin C. Spurling, Maria C. Catalano
  Journal of Clinical Psychopharmacology. 2020-07-01
• Geriatric Psychiatry.
  Dan G Blazer, Susan K Schultz
  Clinics in Geriatric Medicine. 2020-05-01

Journal Articles

• Predictive structural dynamic network analysis  
  Chen R, et al ADNI, J Neurosci Methods, 1/30/2015
• Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease  
  Li R, et al ADNI, PLoS One, 1/28/2015
• Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE  
  Ayton S, et al ADNI, Nat Commun, 1/19/2015
• Brain structure and function as mediators of the effects of amyloid on memory  
  Mattsson N, et al ADNI, Neurology, 1/17/2015
• Memory, executive, and multidomain subtle cognitive impairment: Clinical and biomarker findings  
  Toledo JB et al, ADNI, Neurology, 1/17/2015
• Common genetic variants influence human subcortical brain structures  
  Hibar DP, et al, ADNI, Nature, 1/9/2015
• Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry  
  Shi J, et al, ADNI, Neuroimage, 1/1/2015
• The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function  
  Dowling NM, et al ADNI, Neuroimage, 1/1/2015
• Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement  
  Leung KK, et al ADNI, Neuroimage, 1/1/2015
• Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference  
  Brendel M, et al ADNI, Neuroimage, 1/1/2015
• The future is now: model-based clinical trial design for Alzheimer's disease  
  Romero K, et al; ADNI, Clin Pharmacol Ther, 1/1/2015
• Epidemic spreading model to characterize misfolded proteins propagation  
  Iturria-Medina Y, et al; ADNI, PLoS Comput Biol, 1/20/2014
• Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment  
  Edmonds EC, et al; ADNI, J Int Neuropsychol Soc, 1/1/2014
• Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals  
  Paterson RW, et al ADNI, Transl Psychiatry, 1/1/2014
• Altered effective connectivity patterns of the default mode network in Alzheimer's disease: an fMRI study  
  Zhong Y, et al; ADNI, Neurosci Lett, 1/1/2014
• Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies  
  Pérez-Palma E, et al ADNI; NIA-LOAD/NCRAD Family Study Group, PLoS One, 1/1/2014
• Automatic ROI selection in structural brain MRI using SOM 3D projection  
  Ortiz A, et al, ADNI, PLoS One, 1/1/2014
• Testing for association with multiple traits in generalized estimation equations, with application to neuroimaging data  
  Zhang Y, et al ADNI, Neuroimage, 1/1/2014
•  
  Mattsson N, et al; ADNI, PLoS One, 1/31/2013
• Issues in Selecting Atypical Antipsychotics in Dementia  
  Devanand DP, Schultz SK, Am. J. Psychiatry, 1/1/2013
• Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study  
  Bryant C, et al ADNI, PLoS One, 1/1/2013
• Improved inference in Bayesian segmentation using Monte Carlo sampling: application to hippocampal subfield volumetry  
  Iglesias JE, et al ADNI, Med Image Anal, 1/1/2013
• CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology  
  Bradshaw EM, et al ADNI, Nat Neurosci, 1/1/2013
• Functional activity maps based on significance measures and Independent Component Analysis  
  Martínez-Murcia FJ, et al ADNI, Comput Methods Programs Biomed, 1/1/2013
• Brain changes in older adults at very low risk for Alzheimer's disease  
  Fjell AM, et al ADNI, J Neurosci, 1/1/2013
• Join now to see all

Books/Book Chapters

• Neurobiology of Mental Illness 
  Chapter: DSM-5 Overview and Goals in Neurobiology of Mental Illness 
  Kupfer DJ, Schultz SKEditors: Charney DS, Buxbaum JD, Skar P, Nestler.Oxford, England2014
• Substance Use and Older People 
  Chapter: Epidemiology and Demography of Alcohol and the Older Person 
  Arndt S, Schultz SKEditors: IB Crome, L-T Wu, RT Rao, P Crome.New York: Wiley2014
• Diagnostic and Statistical Manual of Mental Disorders 
  Schultz SKAmerican Psychiatric Association, Arlington, VAEdition 5th,2013
• The Conceptual Evolution of DSM-5 
  Chapter: Part V: Diagnostic Issues Relating to Lifespan from Adulthood into Later Life 
  Faison WE, Schultz SKEditors: Regier DA, Narrow WE, Kuhl E, Kupfer DJ.American Psychiatric Publishing2011
• Psychiatric Diagnosis: A Research Agenda for DSM-V 
  Chapter: Part III: The Elderly. Aging-related diagnostic variations: Age and Gender Considerations 
  Schultz SK, Alexopoulos GSEditors: Narrow WE, First MB, Sirovatka PJ, Regier, DS.American Psychiatric Publishing2007
• Geriatric Review Syllabus 
  Schultz SKAmerican Geriatrics Society and Kendall Hunt publishingEdition 6th,2006
• Aging and Schizophrenia 
  Chapter: Biological changes with aging and schizophrenia 
  Schultz SKEditors: Cohen C.American Psychiatric Press2003
• This Side of Doctoring: Reflections from Women in Medicine 
  Chapter: On reaching visible 
  Schultz SKEditors: Chin EL.Sage Publications, London2002
• Positive and negative symptoms in schizophrenia 
  Fuller R, Schultz SK, Andreasen NEditors: Hirsh.Blackwell Publishing2002
• Current Issues in the Psychopharmacology of Schizophrenia 
  Chapter: The neuroanatomy of schizophrenia 
  Schultz SK, Nopoulos PC, Andreasen NCEditors: Breier A, Tran PV, Herrera J, Bymaster F.Williams and Wilkens, Baltimore, MD2000
• Geriatric Medicine 
  Chapter: Psychotic Disorders in The Geriatric Review Syllabus, A Core Curriculum 
  Schultz SKEditors: Cobbs EL and Duthie EH.American Geriatric SocietyEdition 5th,2000
• The Neuropathology of Schizophrenia 
  Chapter: Integrating functional and structural imaging 
  Andreasen NC and Schultz SKOxford University Press, Oxford, England1999
• Psychiatric Treatment of the Medically Ill 
  Chapter: Effects of aging on psychotropic efficacy and toxicity 
  Schultz SK and Miller DDEditors: Robinson RG and Yates WR.Marcell Decker, Inc, New York, NY1998
• The Geriatric Review Syllabus, A Core Curriculum in Geriatric Medicine 
  Chapter: Contributing question and critique author for Psychotic Disorders 
  Schultz SKEditors: Cobbs EL and Duthie EH.American Geriatric SocietyEdition 4th,1998
• Geriatric Psychopharmacology 
  Chapter: Treatment of poststroke depression 
  Robinson RG, Schultz SK, Paradiso SEditors: Nelson JC.Marcell Decker, Inc, New York, NY1997
• The Textbook of Women's Health 
  Chapter: Brain and Behavior 
  Nopoulos PC, Schultz SK, Andreasen NCEditors: Wallis LA.Little, Brown and Co, Boston, MA1997
• Focus on Depression 
  Chapter: Clinical correlates of early-onset and late-onset poststroke generalized anxiety 
  Castillo CS, Schultz SK, Robinson RGEditors: Vermeulen E.PMSI, Almere-Stad, The Netherlands1996
• Proceedings from Symposium: The Economics of Schizophrenia 
  Chapter: Assessing the symptoms of schizophrenia in Handbook of Mental Health Economics and Health Policy 
  Andreasen NC, Schultz SKEditors: Moscarelli M, Rupp A, Sartorius N.Milan, Italy1993
• Join now to see all

Abstracts/Posters

• Brain pH and Alzheimer’s pathology
  Ponto, LLB, Schultz SK, Jacob M, Menda Y, Magnotta VA, Society for Nuclear Medicine and Molecular Imaging, Annual Meeting, 1/1/2014
• Decisional aides to train non-psychiatrists in evidence based use of antipsychotics in dementia
  Weckmann M, Daly J, Gryzlak B, Kelly M, Lenoch S, Levy B, Reist J, Schultz SK, Seydel L, Smith M, Carnahan R, Academy of Psychosomatic Medicine Annual Meeting; College of Psychiatric and Neurologic Pharmacists Annual Meeting; American Health Care Association/National Center for Assisted Living Quality Symposium, Phoenix, AZ, 2011; Tampa, FL, 2012; Houston, TX, 2012, 1/24/2012
• Development of a reader-friendly patient and family guide to facilitate shared decision making on antipsychotic use in dementia
  Carnahan R, Abrams MA, Weckmann M, Savage B, Daly J, Kelly M, Levy B, Mulhausen P, Reist J, Seydel L, Smith M, Raether R, Abrams E, Holland R, Schultz SK, Health Literacy Iowa and New Readers of Iowa Conference, Des Moines, IA, 1/14/2012
• Structural MRI Correlates of Neurocognitive Performance in Breast Cancer Survivors
  Hamsakutty H, Yamada TH, Denburg N, Magnotta V, Beglinger L, Nopoulos P, Schultz SK, American Association for Geriatric Psychiatry, San Antonio, TX, 1/12/2011
• The Antipsychotic Discontinuation in Alzheimer's Disease (ADAD) trial: clinical rationale and study design
  Devanand DP, Mintzer J, Schultz SK, Sultzer D, de la Pena D, Gupta S, Colon S, Schimming, C, Pelton, G, Andrews H, Levin B, International Congress on Alzheimer's Disease, 1/1/2011
• Dementia, goals of care, and surrogate decision making toward the end of life
  Kaldjian LC, Shinkunas LA, Bern-Klug ME, Schultz SK, Society of General Internal Medicine 32nd Annual Meeting, Miami Beach, FL, 1/14/2009
• [18F]Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Study of Brain Metabolism among Elderly Breast Cancer Survivors
  Schultz SK, Menda Y, Denburg N, Ponto LB, Am. College of Neuropsychopharmacology, Hollywood, FL, 1/7/2009
• Neuropsychological Outcomes of Long-term Breast Cancer Survivors
  Yamada T, Denburg N, Beglinger L, Schultz SK, AAGP, Honlulu, HI, 1/7/2009
• Mild Cognitive Impairment assessed by [15O]water Positron Emission Tomography: Differences in Cerebral Blood Flow among Cognitive Subtypes
  Duff K, Ponto LLB, Moser D, Schultz SK et al, American College of Neuropsychopharmacology, San Juan, Puerto Rico, 1/13/2004
• Cerebrovascular reserve capacity in mild cognitive impairment assessed by [15O] water positron emission tomography
  Schultz SK, Ponto LLB, Magnotta V, et al, American College of Neuropsychopharmacology, San Juan, Puerto Rico, 1/11/2003
• Assessment of cerebrovascular reserve capacity among persons with mild cognitive impairment using [15O] water positron emission tomography
  Schultz SK, Ponto LLB, Magnotta V, et al, American College of Neuropsychopharmacology, San Juan, Puerto Rico, 1/14/2002
• Associations between cognitive impairment and depressive symptoms in late-life: gender effects
  Filips J, Bayless J, Moser DJ, Crossett J, Schultz SK, First Annual International Congress for Geriatric Psychoneuropharmacology, Kona, HI, 1/15/2001
• Psychiatric syndromes in the nursing home patient: longitudinal follow-up study
  Schultz SK, Ellingrod VL, Ekstam-Smith K, et al, American College of Neuropsychopharmacology Annual Meeting, Kona, HI, 1/12/2001
• Clinical characteristics of late-life psychosis: a comparison of diagnostic groups
  Schultz SK, Ellingrod VL, Moser DJ, et al, American Journal of Geriatric Psychiatry, 1/1/2001
• Age and gender effects on the expression of depressive symptoms in schizophrenia
  Schultz SK, Ho BC, Andreasen NC, American College of Neuropsychopharmacology Annual Meeting, 1/1/2000
• Effects of psychiatric symptoms on functional skills among long-term care patients
  Schultz SK, Ellingrod V, Moser D, Arndt S, NCDUE annual meeting, Boca Raton, FL, 1/1/2000
• The relationship between neuroleptic-induced akathisia and depressive symptoms
  Atbasoglu C, Schultz SK, Andreasen NC, APA Annual Meeting, 1/1/2000
• Association between cytochrome P4502D6 (CYP2D6) genotype, neuroleptic exposure, and abnormal involuntary movements
  Ellingrod VL, Schultz SK, Arndt S, International Congress for Schizophrenia Research Annual meeting, 1/1/1999
• A positron emission tomography study of age-related changes in regional cerebral blood flow
  Schultz SK, O’Leary DS, Andreasen NC, Society for Neuroscience 28th Annual Meeting, 1/1/1998
• A retrospective analysis of the hypoglycemic treatment of schizophrenia
  Schultz SK and Dornink R, Am J Geriatr Psychiatry, 1/1/1998
• Clinical variables associated with suicide in patients with schizophrenia
  Ziebell S, Schultz SK, Andreasen NC, Schizophrenia Research, 1/1/1997
• Effects of low versus high potency neuroleptic withdrawal on symptoms and dyskinetic movements
  Schultz SK, Miller DD, Arndt S, Andreasen NC, Schiz Research, 1/1/1997
• Sympathetic activity and metabolic rate in patients with anorexia nervosa
  Schultz SK, Van de Borne P, Anderson E, American Psychiatric Association Annual Meeting, 1/1/1997
• Heart rate variability before and after electroconvulsive therapy in patients with major depressive disorder
  Schultz SK, Van de Borne P, Anderson E, Proceedings of the American Association for Geriatric Psychiatry annual meeting, 1/1/1997
• Schizophrenia and aging: a comparison of symptoms among age groups
  Schultz SK, Oliver S, Arndt S, Miller D, Andreasen NC, Am J Geriatr Psychiatry, 1/1/1996
• Join now to see all

Lectures

• APA Council on Aging 
  1/18/2015
• Advances in Geriatric Psychiatry 
  Toronto, ON - 1/17/2015
• Non-AD Dementias and Delirium 
  1/1/2015
• Understanding the Diagnosis and Progression of Memory Decline and Dementia 
  1/28/2014
• New Tests to Help Diagnose Alzheimer’s Disease 
  Lone Tree, IA - 1/28/2014
• Breakthroughs in Science, Beneficence in Care 
  Orlando, FL - 1/17/2014
• Diagnostic Imaging in Alzheimer’s and Other Dementias 
  Iowa City, IA - 1/25/2013
• Healthcare in the Elderly 
  Iowa City, IA - 1/25/2013
• New Advances in Alzheimer’s Research 
  1/12/2012
• Brain Imaging and New Diagnostic Measures for Alzheimer’s Disease 
  Iowa City, IA - 1/3/2012
• Managing Dementia Patients with Behavioral Disturbances 
  Des Moines, IA - 1/2/2012
• Managing Behavioral Symptoms of Dementia 
  Chicago, IL - 1/17/2011
• New Research on the Diagnosis and Treatment of Alzheimer’s Disease 
  1/16/2011
• Emotional and Behavioral Problems with Aging 
  Waterloo, IA - 1/16/2011
• Risk Factors for Mild Cognitive Impairmen 
  Chicago, IL - 1/16/2011
• Psychiatric Issues for Older Adults 
  Iowa City, IA - 1/7/2011
• Potential Cognitive Effects of Chemotherapy among Long-term Cancer Survivors 
  Pittsburgh, PA - 1/26/2010
• Understanding Neuropsychological Outcomes among Women Breast Cancer Survivors 
  Minneapolis, MN - 1/17/2010
• Diagnosis of Dementia 
  1/10/2010
• Cancer and Aging: Breast Cancer Survivors and Cognitive Outcomes 
  Savannah, GA - 1/7/2010
• Management of Emotional Problems in Dementia 
  1/1/2010
• Elderly Women Breast Cancer Survivors: Cognitive Outcomes 
  1/15/2009
• Emerging Immunotherapies for Alzheimer’s Disease 
  1/13/2009
• Emotional Changes in Late life: Issues for Caregivers 
  1/12/2009
• Mechanisms and Emerging Treatments for Alzheimer’s Disease 
  1/12/2009
• Join now to see all

Other

• Memory Problems 
  Schultz SK, American Geriatrics Society's Foundation for Health in Aging (FHA)
  http://www.healthinaging.org/public_education/eldercare/17.xml
  1/1/2003
• Dementia Teaching Module 
  Schultz SK, Iowa Geriatric Education Center (IGEC)
  1/1/2000